Fragale A, Stellacci E, Romagnoli G, Licursi V, et al. Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects. Int J Cancer 2023 Jun 9. doi: 10.1002/ijc.34602.
PMID: 37293858